CD4 and breast cancer: hASCs had the potential to activate and induce proliferation of resting allogeneic CD4 T cell fraction of PBMCs (Crop et al. 2010), or naïve CD4 T cells, derived from breast cancer patients (Frazier et al. 2014) in direct and/or transwell co-culture.